Dr. Lal Path Labs Share price Rises 3% After Adopting AI Cancer Detection Tool

Dr. Lal Path Labs share price (NSE: LALPATHLAB) jumped 3.2% on August 20, 2025, hitting an intra-day high of ₹3,496.75 on the BSE. By 11:37 AM, the stock was up 1.96% at ₹3,454.3, while the Sensex rose 0.14% to 81,756.74.

First in India to Use AI Cancer Diagnostic Tool

The company became the first laboratory in India to adopt a deep learning-based AI tool to detect lymph node metastasis, including tiny clusters of cancer cells called micrometastases. This technology, developed in collaboration with Qritive, was showcased at USCAP 2025, a leading global pathology conference.

How the AI Tool Works

The tool, called QiAI Lymph Node Dx, uses deep learning to scan digital slides and accurately detect cancer cells. Detecting micrometastases usually requires extra time and complex tests, but this AI tool speeds up the process and improves accuracy.

Clinical Importance

Finding cancer spread in lymph nodes is crucial for determining the stage and treatment of the disease. Missing early signs of metastasis can allow cancer to spread to other organs, reducing survival chances. By spotting even single cancer cells early, the AI system could have a major impact on treatment planning and patient outcomes.

Testing and Validation

The AI system was tested on cases of breast, colon, stomach, and esophageal cancers. It successfully detected cancer cells that were missed during manual reviews. These findings were later confirmed through immunohistochemistry (IHC), proving its reliability.Also Read: Low Acceptance Rate in the Second Round of PM Internship Scheme Raises Concerns!

Also Read: Low Acceptance Rate in the Second Round of PM Internship Scheme Raises Concerns!

About Dr. Lal Path Labs

Dr. Lal Path Labs is one of India’s leading diagnostic service providers. As of March 31, 2025, the company operates 298 clinical laboratories, including its National Reference Lab in Delhi and regional labs in Kolkata, Bangalore, and Mumbai.

Conclusion

By introducing AI-powered cancer diagnostics, Dr. Lal Path Labs has taken a major step towards faster and more accurate cancer detection. This not only boosts its credibility as an innovator but also holds the potential to improve cancer treatment outcomes in India.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities market are subject to market risks, read all the related documents carefully before investing.